ClinicalTrials.govpublic full text
Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC
gastric cancer, adjuvant therapy, elderly patients, tislelizumab, chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007389
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.